These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 521485)

  • 1. Time of lymphocyte response after onset of tularemia and after tularemia vaccination.
    Tärnvik A; Sandström G; Löfgren S
    J Clin Microbiol; 1979 Dec; 10(6):854-60. PubMed ID: 521485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-mediated and humoral immunity induced by a live Francisella tularensis vaccine.
    Koskela P; Herva E
    Infect Immun; 1982 Jun; 36(3):983-9. PubMed ID: 7095859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-lasting cell-mediated immunity induced by a live Francisella tularensis vaccine.
    Tärnvik A; Löfgren ML; Löfgren S; Sandström G; Wolf-Watz H
    J Clin Microbiol; 1985 Oct; 22(4):527-30. PubMed ID: 3878364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of human lymphocytes by a vaccine strain of Francisella tularensis.
    Tärnvik A; Löfgren S
    Infect Immun; 1975 Nov; 12(5):951-7. PubMed ID: 1193733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expansion of Vgamma9 Vdelta2 T cells is triggered by Francisella tularensis-derived phosphoantigens in tularemia but not after tularemia vaccination.
    Poquet Y; Kroca M; Halary F; Stenmark S; Peyrat MA; Bonneville M; Fournié JJ; Sjöstedt A
    Infect Immun; 1998 May; 66(5):2107-14. PubMed ID: 9573096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory and oral vaccination improves protection conferred by the live vaccine strain against pneumonic tularemia in the rabbit model.
    Stinson E; Smith LP; Cole KS; Barry EM; Reed DS
    Pathog Dis; 2016 Oct; 74(7):. PubMed ID: 27511964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial.
    Mulligan MJ; Stapleton JT; Keitel WA; Frey SE; Chen WH; Rouphael N; Edupuganti S; Beck A; Winokur PL; El Sahly HM; Patel SM; Atmar RL; Graham I; Anderson E; El-Kamary SS; Pasetti MF; Sztein MB; Hill H; Goll JB;
    Vaccine; 2017 Aug; 35(36):4730-4737. PubMed ID: 28750854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of a new lot of Francisella tularensis live vaccine strain in human volunteers.
    Waag DM; Sandström G; England MJ; Williams JC
    FEMS Immunol Med Microbiol; 1996 Mar; 13(3):205-9. PubMed ID: 8861030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen from Francisella tularensis: nonidentity between determinants participating in cell-mediated and humoral reactions.
    Sandström G; Tärnvik A; Wolf-Watz H; Löfgren S
    Infect Immun; 1984 Jul; 45(1):101-6. PubMed ID: 6203835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A.
    Wu TH; Hutt JA; Garrison KA; Berliba LS; Zhou Y; Lyons CR
    Infect Immun; 2005 May; 73(5):2644-54. PubMed ID: 15845466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Inner and Outer Membrane Proteins from
    Post DMB; Slütter B; Schilling B; Chande AT; Rasmussen JA; Jones BD; D'Souza AK; Reinders LM; Harty JT; Gibson BW; Apicella MA
    mBio; 2017 Oct; 8(5):. PubMed ID: 29018123
    [No Abstract]   [Full Text] [Related]  

  • 12. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.
    Baron SD; Singh R; Metzger DW
    Infect Immun; 2007 May; 75(5):2152-62. PubMed ID: 17296747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Francisella tularensis antigen responses measured as T-lymphocyte proliferation and cytokine production (tumor necrosis factor alpha, gamma interferon, and interleukin-2 and -4) during human tularemia.
    Surcel HM; Syrjälä H; Karttunen R; Tapaninaho S; Herva E
    Infect Immun; 1991 Jun; 59(6):1948-53. PubMed ID: 1674737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful protection against tularemia in C57BL/6 mice is correlated with expansion of Francisella tularensis-specific effector T cells.
    Griffin AJ; Crane DD; Wehrly TD; Bosio CM
    Clin Vaccine Immunol; 2015 Jan; 22(1):119-28. PubMed ID: 25410207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 2 and gamma interferon production, interleukin 2 receptor expression, and DNA synthesis induced by tularemia antigen in vitro after natural infection or vaccination.
    Karttunen R; Andersson G; Ekre HP; Juutinen K; Surcel HM; Syrjälä H; Herva E
    J Clin Microbiol; 1987 Jun; 25(6):1074-8. PubMed ID: 3110207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of the basic immunological reactions for assessing tularemia immunity in inoculated persons or those who have had the disease].
    Kamennova LS; Pokrovskaia VI; Vasil'eva VP; Petrova LI; Liubomudrov VB
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Nov; (11):92-5. PubMed ID: 6659772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of vaccinated mice against pneumonic tularemia is associated with an early memory sentinel-response in the lung.
    Bar-On L; Cohen H; Elia U; Rotem S; Bercovich-Kinori A; Bar-Haim E; Chitlaru T; Cohen O
    Vaccine; 2017 Dec; 35(50):7001-7009. PubMed ID: 29102170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
    Tian D; Uda A; Park ES; Hotta A; Fujita O; Yamada A; Hirayama K; Hotta K; Koyama Y; Azaki M; Morikawa S
    Microbiol Immunol; 2018 Jan; 62(1):24-33. PubMed ID: 29171073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of subpopulations of human lymphocytes by a vaccine strain of Francisella tularensis.
    Tärnvik A; Holm SE
    Infect Immun; 1978 Jun; 20(3):698-704. PubMed ID: 307538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of opsonizing antibodies to Francisella tularensis by leukocyte chemiluminescence.
    Löfgren S; Tärnvik A; Carlsson J
    Infect Immun; 1980 Aug; 29(2):329-34. PubMed ID: 7216416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.